Balchem Newsroom

HC Wainwright & Co. : The Balchem (BCPC.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $167.00 to $170.00.

Zhitong FinanceMay 6 18:31

Buy Rating Affirmed for Balchem With Strong Q1 Performance and Positive Growth Outlook

TipRanksMay 6 18:31

Balchem Analyst Ratings

BenzingaMay 6 18:31

HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $170

BenzingaMay 6 18:30

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $135

BenzingaOct 30, 2023 18:53

Balchem Analyst Ratings

BenzingaOct 30, 2023 18:51

HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $165

BenzingaJul 31, 2023 18:13

Balchem Analyst Ratings

BenzingaJul 31, 2023 18:13

HC Wainwright Adjusts Price Target on Balchem to $150 From $140, Keeps Buy Rating

MT NewswiresJun 5, 2023 20:01

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN) and Balchem (BCPC)

TipRanksJun 5, 2023 18:20

HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $150

BenzingaJun 5, 2023 18:08

HC Wainwright Adjusts Price Target on Balchem to $140 From $152, Keeps Buy Rating

MT NewswiresFeb 27, 2023 22:15

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140

BenzingaFeb 27, 2023 19:10

HC Wainwright Adjusts Price Target on Balchem to $152 From $164, Maintains Buy Rating

MT NewswiresNov 7, 2022 22:45

Balchem Analyst Ratings

Benzinga Analyst RatingsNov 7, 2022 19:42

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152

Benzinga Real-time NewsNov 7, 2022 19:41

H.C. Wainwright Sticks to Its Buy Rating for Balchem (BCPC)

TipRanksNov 7, 2022 19:30